Federal contract award
HT942525F0114
SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY (AOR).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN14 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES |
| Parent award / vehicle | HT001122D0053 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $4.9M |
| Current contract value | $5.4M |
| Potential contract value / ceiling | $15.4M |
| Start date | Mar 13, 2025 |
| Current end date | Mar 13, 2027 |
| Potential end date | Mar 12, 2030 |
| Latest award activity | May 12, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 12, 2026 | P00008 | $733.1K | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE |
| Apr 1, 2026 | P00007 | $0 | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE |
| Feb 27, 2026 | P00006 | $1.4M | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE |
| Feb 12, 2026 | P00005 | $-188.0K | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY. |
| Feb 5, 2026 | P00004 | $0 | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY. |
| Aug 5, 2025 | P00003 | $0 | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY. |
| Jun 6, 2025 | P00002 | $458.0K | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY. |
| Apr 23, 2025 | P00001 | $230.3K | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY (AOR). |
| Mar 12, 2025 | 0 | $2.0M | SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SUPPORT FOR INFECTIOUS DISEASE RESEARCH AND SURVEILLANCE TO IDENTIFY AND CHARACTERIZE MEDICAL THREATS TO THE WARFIGHTER IN AREA OF RESPONSIBILITY (AOR). |
Estimated positioning window
Mar 12, 2029 – Sep 12, 2029
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2030-03-12 (1234 days from calculation)
- +5 points
- 20 historical awards in this buyer and category group
- +15 points
- 9 recorded award transactions
- +10 points
- Latest award action: 2026-05-12
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.